Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Novakand Pharma AB

Closing information (x1000 EUR)

Closing information 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Turnover 1 More Arrow 93 Less Arrow 68
Financial expenses 0 More Arrow 12 More Arrow 56
Earnings before taxes -3,880 Less Arrow -5,848 More Arrow -4,716
EBITDA -4,019 Less Arrow -5,862 More Arrow -4,634
Total assets 5,825 More Arrow 5,916 More Arrow 10,850
Current assets 4,258 More Arrow 4,294 More Arrow 8,940
Current liabilities 401 More Arrow 1,620 Less Arrow 1,242
Equity capital 5,424 Less Arrow 4,296 More Arrow 9,607
- share capital 1,025 Less Arrow 714 More Arrow 5,955
Employees (average) 5 Less Arrow 4 More Arrow 8

Financial ratios

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Solvency 93.1% Less Arrow 72.6% More Arrow 88.5%
Turnover per employee 0 More Arrow 23 Less Arrow 8
Profit as a percentage of turnover -388000% More Arrow -6288.2% Less Arrow -6935.3%
Return on assets (ROA) -66.6% Less Arrow -98.6% More Arrow -42.9%
Current ratio 1061.8% Less Arrow 265.1% More Arrow 719.8%
Return on equity (ROE) -71.5% Less Arrow -136.1% More Arrow -49.1%
Change turnover -89 More Arrow 25 Less Arrow -85
Change turnover % -99% More Arrow 37% Less Arrow -56%
Chg. No. of employees 1 Less Arrow -4 More Arrow 0
Chg. No. of employees % 25% Less Arrow -50% More Arrow 0%

Total value of public sale

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.